×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| SANDU PHARMACEUTICALS LTD. | NA | NA | NA | NA | 47.2 | 30.5 |
| Deccan Health Care Limited | NA | NA | NA | NA | 46.6 | 45.3 |
| GUJARAT TERCE LABORATORIES LTD | NA | NA | NA | NA | 42.8 |
Sandu Pharmaceuticals Ltd., with Security Code 524703, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17.1 | 15.3 | 17.7 | 16.6 | 17.4 | 15.6 | 17.0 | 17.7 | 18.4 | 14.1 |
| Expenses | 16.3 | 14.8 | 17.3 | 15.8 | 16.9 | 15.0 | 16.6 | 16.8 | 17.4 | 13.5 |
| Operating Profit | 0.8 | 0.5 | 0.4 | 0.8 | 0.5 | 0.6 | 0.4 | 0.9 | 1.0 | 0.5 |
| OPM % | 4.8% | 3.16% | 2.01% | 4.97% | 2.94% | 3.88% | 2.38% | 5.18% | 5.39% | 3.86% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.1 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Profit before tax | 0.7 | 0.4 | 0.2 | 0.8 | 0.4 | 0.7 | 0.3 | 0.7 | 0.8 | 0.4 |
| Tax % | -31.1% | -27.5% | -47.9% | -27.9% | -45.2% | -17.4% | -38.4% | -32.8% | -30.4% | 0% |
| Net Profit | 0.5 | 0.3 | 0.1 | 0.6 | 0.2 | 0.6 | 0.2 | 0.5 | 0.6 | 0.3 |
| EPS in Rs | 0.52 | 0.27 | 0.11 | 0.57 | 0.21 | 0.5 | 0.17 | 0.52 | 0.57 | 0 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 16.8 | 17.1 | 15.3 | 17.7 | 16.6 | 17.4 | 15.6 | 17.0 | 17.7 | 14.1 |
| Expenses | 15.9 | 16.3 | 14.8 | 17.3 | 15.8 | 16.9 | 15.0 | 16.6 | 16.8 | 13.5 |
| Operating Profit | 0.9 | 0.8 | 0.5 | 0.4 | 0.8 | 0.5 | 0.6 | 0.4 | 0.9 | 0.5 |
| OPM % | 5.13% | 4.79% | 3.15% | 2.01% | 4.97% | 2.93% | 3.88% | 2.38% | 5.14% | 3.86% |
| Other Income | 0.2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.3 | 0.0 | 0.0 | 0.1 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 |
| Profit before tax | 0.9 | 0.7 | 0.4 | 0.2 | 0.8 | 0.4 | 0.7 | 0.3 | 0.7 | 0.4 |
| Tax % | -31.8% | -31% | -27.9% | -47.9% | -28% | -45.2% | -17.4% | -38.4% | -32.8% | 0% |
| Net Profit | 0.6 | 0.5 | 0.3 | 0.1 | 0.6 | 0.2 | 0.6 | 0.2 | 0.5 | 0.3 |
| EPS in Rs | 0.64 | 0.51 | 0.26 | 0.11 | 0.57 | 0.21 | 0.62 | 0.17 | 1.95 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 17% |
| 3 Years: | 10% |
| TTM: | 60% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 28% |
| 3 Years: | -9% |
| 1 Year: | -7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 28% |
| 3 Years: | -9% |
| 1 Year: | -7% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|